Target intelligence / Profile preview

Bacterial cell wall (peptidoglycan) and cell membrane

Molecular classification
Other (structural component), Enzyme, Transporter
01

Overview

The **bacterial cell wall** is a vital, mesh-like structure primarily composed of **peptidoglycan**, which protects bacterial cells from osmotic lysis, maintains cell shape, and provides structural integrity[1][2][4]. The **cell wall** is synthesized from cytoplasmic precursors (notably, the lipid-linked disaccharide-pentapeptide "lipid II") that are flipped across the **cytoplasmic (plasma) membrane** by specialized transporters (e.g., MurJ), where they are polymerized and cross-linked by penicillin-binding proteins and other enzymes[1][3][7]. The **bacterial cell membrane** is a phospholipid bilayer that encapsulates the cytoplasm and mediates crucial processes including energy generation, nutrient uptake, and transport of wall precursors[5][6]. Both the cell wall and membrane are canonical targets for antibacterial agents—many antibiotics block cell wall synthesis, while others disrupt the cell membrane, leading to bacterial death or lysis[2][4][5]. These structures are not unique to a single molecular target but represent essential, druggable features of bacteria that are absent or fundamentally different from those of human cells, enabling selective toxicity[2][4][5].

Other names
Bacterial cell envelopeCell envelopePeptidoglycan layer (for the wall)Cytoplasmic membranePlasma membrane
02

Mechanism of action

Inhibition of peptidoglycan synthesis (via transpeptidase or glycosyltransferase inhibition) Disruption of cell wall precursor trafficking (e.g., MurJ inhibition) Permeabilization or disruption of the cell membrane integrity

03

Biological functions

Structural integrityShape maintenanceOsmotic protectionCell divisionAdaptation and resistance
04

Disease associations

Infection (essential for bacterial survival and virulence)Antibiotic resistance (modifications contribute to drug resistance)
05

Safety considerations

Off-target effects on human cell membranes by some drugs (e.g., nephrotoxicity of polymyxins)Potential disruption of beneficial microbiota
06

Interacting drugs

β-lactams (e.g., penicillins, cephalosporins—target cell wall synthesis)

6 more in the full profile.

07

Biomarkers

Detection of specific peptidoglycan or precursors (for infection)Resistance genes (e.g., mecA for β-lactam resistance)

Beyond the preview

Go deeper on Bacterial cell wall (peptidoglycan) and cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall (peptidoglycan) and cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call